How do you improve patient recruitment and diversity in clinical trials?

Engaging community physicians (provider-engagement models) widens access to larger, more diverse patient populations, while Latin America's large, treatment-naïve populations help sponsors meet FDA Diversity Action Plan expectations — and recruit faster.

From the Global Trial Accelerators™ podcast with Scott Stout (MedVector): watch the episode.

What drives faster, more diverse recruitment

• Provider-engagement models reach patients through trusted community physicians
• Large, treatment-naïve Latin American populations enroll quickly
• Diversity that supports FDA Diversity Action Plan (DAP) requirements
• Centralized high-volume sites shorten enrollment timelines

FDA acceptance of LATAM data · Clinical trial services